Vulnerability Description
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.
CVSS Score
HIGH
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Baxter | Prismaflex Firmware | All versions |
| Baxter | Prismaflex | - |
| Baxter | Prismax Firmware | < 3.0 |
| Baxter | Prismax | - |
Related Weaknesses (CWE)
References
- https://www.us-cert.gov/ics/advisories/icsma-20-170-01Not Applicable
- https://us-cert.cisa.gov/ics/advisories/icsma-20-170-02Third Party Advisory
- https://www.us-cert.gov/ics/advisories/icsma-20-170-01Not Applicable
FAQ
What is CVE-2020-12037?
CVE-2020-12037 is a vulnerability with a CVSS score of 7.5 (HIGH). Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Pa...
How severe is CVE-2020-12037?
CVE-2020-12037 has been rated HIGH with a CVSS base score of 7.5/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2020-12037?
Check the references section above for vendor advisories and patch information. Affected products include: Baxter Prismaflex Firmware, Baxter Prismaflex, Baxter Prismax Firmware, Baxter Prismax.